Keywords: strong, hcv, clearance, data, r1626, regimen, swiss

Strong HCV clearance data for R1626 regimen

Article | 21 November 2007

Print This

R1626, one of Swiss drug major Roche's new investigational drugs for hepatitis C, has shown promising antiviral efficacy when given ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in